I Sens develops specialized diabetes-management software focused on blood glucose tracking and monitoring; its vulnerability footprint remains confined to this targeted product domain. Treat this as a compact vendor profile reflecting a narrowly scoped application surface rather than a broad trend line; live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by I Sens over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2017-13993HIGH An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element v | Oct 5, 2017 | 7.8 | 24 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by I Sens.
Media articles that mention a CVE ID that affects a product developed by I Sens — matched by CVE ID, not by vendor name.